Hong Kong Healthtech Stock News

Chongqing Rural Commercial Bank (SEHK:3618) drew fresh attention after announcing that president and executive director Mr. Sui Jun resigned due to a job transfer, with chairman Mr. Liu Xiaojun temporarily taking on presidential duties. See our latest analysis for Chongqing Rural Commercial Bank. At a share price of HK$6.57, Chongqing Rural Commercial Bank has seen short term momentum build, with a 1 month share price return of 9.87%. However, the 3 month share price return is down 5.47%,...

Shenzhen International Holdings (SEHK:152) has drawn investor attention after completing a RMB 1,000 million issuance of 5 year medium term notes at a 1.72% coupon, a fresh debt financing that could influence its capital structure. See our latest analysis for Shenzhen International Holdings. For context, Shenzhen International Holdings' share price has moved to HK$6.19, with a 1 month share price return of 13.16% but a year to date share price return that is down 28.11%, while the 1 year...

ICBC loan pricing reform and what it may mean for investors Industrial and Commercial Bank of China (SEHK:1398) has begun piloting loans priced off interbank repurchase agreement rates instead of the loan prime rate. This shift highlights ongoing reforms in China’s approach to bank funding and loan pricing. See our latest analysis for Industrial and Commercial Bank of China. At a share price of HK$7.48, Industrial and Commercial Bank of China has logged a 1-month share price return of 12.99%...

Wing Lee Development Construction Holdings came into today with its stock at HK$0.89 and a three month share price decline of about 21%. Yet the latest full year earnings tell a different story about where the real pressure sits. The headline is margin strain. Net profit margin over the last 12 months sits at 3% compared with 7.7% a year earlier, while the stock still trades on a trailing P/E of 48.3x against an industry average of 12.2x. The market is already uneasy and this earnings mix...

In July 2026, InnoCare Pharma reported that its oral TYK2 allosteric inhibitor fadeucravacitinib (ICP-488) met the primary endpoint with statistically significant, clinically meaningful benefits and a consistent safety profile in a registrational Phase III trial for adults with moderate-to-severe plaque psoriasis. This success further underscores InnoCare’s push into oral TYK2 therapies across multiple autoimmune skin diseases, potentially broadening its late-stage dermatology portfolio...

China Gas Holdings (SEHK:384) has called an annual general meeting for 21 August 2026 in Shenzhen, where shareholders are set to vote on a final dividend and a share buyback mandate of up to 10% of issued shares. See our latest analysis for China Gas Holdings. At the current share price of HK$5.97, China Gas Holdings has seen short term share price momentum pick up, with a 1 month share price return of 5.66%, although the 1 year total shareholder return is down 24.77%, which points to still...

In recent weeks, Asian markets have shown resilience despite global economic uncertainties, with indices reflecting a mix of cautious optimism and volatility driven by geopolitical tensions and fluctuating oil prices. In this environment, identifying undervalued stocks becomes crucial as investors seek opportunities that offer potential for growth at discounted valuations.

Amidst a backdrop of escalating geopolitical tensions and fluctuating oil prices, Asian markets have been navigating a complex landscape. This environment has brought renewed attention to penny stocks, which, despite being an older term, continue to offer intriguing opportunities for investors. These smaller or newer companies can provide significant growth potential when supported by strong financials and sound fundamentals, making them compelling options for those seeking hidden value in...

As geopolitical tensions and rising oil prices continue to influence global markets, Asia's stock indices have shown resilience, buoyed by strategic investments in technology and infrastructure. In this environment, growth companies with high insider ownership can signal strong insider confidence, a key factor for investors seeking stability amid market fluctuations.

Even though Ficus Technology Holdings Limited ( HKG:8107 ) has fallen by 13% over the past week , insiders who sold...

Insiders who bought HK$56.3m worth of Kwan On Holdings Limited ( HKG:1559 ) stock in the last year have seen some of...

The recent price decline of 21% in Fenbi Ltd.'s ( HKG:2469 ) stock may have disappointed insiders who bought CN¥7.22m...

A lackluster earnings announcement from Grand Brilliance Group Holdings Limited ( HKG:8372 ) last week didn't sink the...

A lackluster earnings announcement from Edvance International Holdings Limited ( HKG:1410 ) last week didn't sink the...

The market rallied behind Progressive Path Group Holdings Limited's ( HKG:1581 ) stock, leading do a rise in the share...

Damai Entertainment Holdings Limited ( HKG:1060 ) just reported healthy earnings but the stock price didn't move much...

Insiders who bought CN¥23.7m worth of Golden Wheel Tiandi Holdings Company Limited ( HKG:1232 ) stock in the last year...

As geopolitical tensions in the Middle East and fluctuating oil prices continue to influence global markets, Asian equities have shown resilience, with indices like Japan's Nikkei 225 and China's CSI 300 posting gains. In such a dynamic environment, dividend stocks can offer investors a degree of stability and income potential, making them an attractive option for those looking to navigate market volatility while seeking consistent returns.

Amidst a backdrop of geopolitical tensions and rising oil prices, Asian markets have shown resilience, with some indices advancing despite global uncertainties. In this environment, growth companies with high insider ownership can offer unique insights into potential long-term value, as insiders often align their interests closely with shareholders.

We didn't see Herald Holdings Limited's ( HKG:114 ) stock surge when it reported robust earnings recently. We think...

HBM Holdings (SEHK:2142) is back in focus after Harbour BioMed agreed to form the Sinopharm Harbour BioMed Innovation Consortium with China National Pharmaceutical Group, centered on research and development of biologic drugs. See our latest analysis for HBM Holdings. Against this backdrop, HBM Holdings has been volatile, with the share price falling 1.74% over the past day but posting a 23.26% 1 month share price return. The 3 year total shareholder return is very large, signalling strong...

China Mobile (SEHK:941) has rolled out an AI powered overhaul of its core calling services, adding HD audio and video, live captions, fraud screening and interactive business features within the standard dialer. See our latest analysis for China Mobile. Against this AI rollout backdrop, China Mobile’s share price has shown firm short term momentum, with a 7.56% 1 month share price return, while its 3 year total shareholder return of 56.15% points to solid longer term compounding. If this AI...

Chinese semiconductor stocks are under fresh scrutiny as global chipmakers face selling pressure, new competition from China and questions about whether huge AI infrastructure spending will really pay off. While companies like Micron, SK Hynix and Nvidia are in the headlines, the ripple effects extend across the sector, including China and Hong Kong. This article looks at how that news backdrop connects to our Chinese Semiconductor Industry screener and highlights 3 stocks that appear...

Investors pushed Bosideng International Holdings slightly lower over the past week even as the stock sits roughly 24% higher over the past month. That hesitation contrasts with a set of full year numbers that show earnings up 13.7% over the last 12 months and a healthier 14.6% net profit margin. The market is still pricing Bosideng at a P/E of 12.3x, a premium to both its peers and the wider Hong Kong luxury sector. However, the latest valuation model points to a fair value above the current...